Company: BLNE
Filing Date: 2025-11-14
Form Type: 424B3
Source: 0001493152-25-023493
Chunk: 23

Company: Beeline Holdings, Inc.
Filing Date: 2025-11-14
Form: 424B3
Chunk 23
---
 in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

We estimate that the total expenses for the offering will be approximately $35,000.

C/M has represented to us that at no time prior to the date of the Purchase Agreement has C/M or its agents, representatives or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock or any hedging transaction, which establishes a net short position with respect to our common stock. C/M has agreed that during the term of the Purchase Agreement, neither C/M, nor any of its agents, representatives or affiliates will enter into or effect, directly or indirectly, any of the foregoing transactions.

We have advised C/M that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes C/M, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this prospectus.

This offering will terminate on the date that all of our common stock offered by this prospectus have been sold by C/M.

Our common stock is currently listed on Nasdaq under the symbol “BLNE”.

| 19 |

<div align='center'>DESCRIPTION OF CAPITAL STOCK</div>

Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.0001 per share, of which 23,135,155 shares are outstanding as of November 10, 2025, and 100,000,000 shares of “blank check” preferred stock, par value $0.0001 per share, of which 8,425,102 shares of Series A are authorized and of which 6,425,102 shares are outstanding, 2,500,000 shares of Series B are authorized and of which 2,500,000 shares are outstanding, 255,474 shares of Series D are authorized and of which 0 shares are outstanding, 200,000 shares of Series E are